Panel A shows a flowchart of patient selection and follow-up in this study. Panel B shows the mean number of angiodysplastic lesions per patient before transcatheter aortic-valve replacement (TAVR) ...
People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial ...
WASHINGTON, DC—Intervening early in patients with severe aortic stenosis (AS) but no symptoms may be more beneficial than watchful waiting, according to results from the EARLY TAVR trial. At a median ...
Results from Cardiawave’s Valvosoft pivotal study of 60 patients with severe symptomatic calcific aortic stenosis suggest treatment with the investigational noninvasive ultrasound therapy device ...
Please provide your email address to receive an email when new articles are posted on . Percutaneous intervention bested surgical treatment of severe aortic stenosis and complex CAD. The trial was ...
People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial ...
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lacking ...
Limited launch expected for JenaValve's Trilogy System ...
Modern medicine has advanced dramatically, yet one of the most common causes of sudden cardiac death continues to go undetected: heart valve disease, particularly aortic stenosis. This condition ...
Morgantown-based West Virginia University Heart and Vascular Institute is offering robotic procedures for aortic stenosis, a common and potentially fatal heart valve disease, providing patients with ...
Please provide your email address to receive an email when new articles are posted on . Electronic provider notification led to more aortic valve replacement procedures after a diagnosis of severe ...
Cardiawave, a pioneering medtech company developing non-invasive ultrasound therapy (NIUT) for aortic stenosis, has received CE Certificate for Valvosoft®, the world’s first non-invasive therapeutic ...